[1] Hedinger C, Williams ED, Sobin LH.The WHO histological classification of thyroid tumours:a commentary on the second edition[J]. Cancer, 1989, 63(5):908911.
[2] Yu XM, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases[J]. Ann Surg, 2011, 254(4):653660.
[3] Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):2835.
[4] Bernet V. Approach to the patient with incidental papillary microcarcinoma[J]. J Clin Endocrinol Metab, 2010, 95(8):35863592.
[5] Nucera C, Pontecorvi A. Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?[J]. Front Endocrinol (Lausanne), 2012, 3:33.
[6] Buffet C, Golmard JL, Hoang C, et al. Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma[J]. Eur J Endocrinol, 2012, 167(2): 267275.
[7] Mantinan B, RegoIraeta A, Larraaga A, et al. Factors Influencing the Outcome of Patients with Incidental Papillary Thyroid Microcarcinoma[J]. J Thyroid Res, 2012,2012:469397.
[8] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 7(6):14711474.
[9] Cho JK, Kim JY, Jeong CY, et al. Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age[J]. J Korean Surg Soc, 2012, 82(5):281287.
[10] Neuhold N, Schultheis A, Hermann M, et al. Incidental papillary microcarcinoma of the thyroidfurther evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of followup[J]. Ann Surg Oncol, 2011, 18(12):34303436.
[11] Kuo SF, Lin SF, Chao TC, et al. Prognosis of Multifocal Papillary Thyroid Carcinoma[J]. Int J Endocrinol, 2013, 2013:809382.
[12] Kuo SF, Chao TC, Chang HY, et al. Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma[J]. J Formos Med Assoc, 2011, 110(8):511517.
[13] Karatzas T, Vasileiadis I, Charitoudis G, et al. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy[J]. Hormones (Athens), 2013, 12(4):529536.
[14] Lee J, Song Y, Soh EY. Central Lymph Node Metastasis Is an Important Prognostic Factor in Patients with Papillary Thyroid Microcarcinoma[J]. J Korean Med Sci, 2014, 29(1):4852.
[15] Anastasilakis AD, Polyzos SA, Makras P, et al. Papillary thyroid microcarcinoma presenting as lymph node metastasis a diagnostic challenge: case report and systematic review of literature[J]. Hormones (Athens), 2012,11(4):419427.
[16] Caliskan M, Park JH, Jeong JS, et al. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma[J]. Endocr J, 2012, 59(4):305311.
[17] Liu Z, Wang L, Yi P, et al. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a metaanalysis[J]. Int J Clin Exp Pathol, 2014, 7(3):932937.
[18] Muntean V, Domsa I, Zolog A, et al. Incidental papillary thyroid microcarcinoma: is completion surgery required?[J]. Chirurgia (Bucur), 2013, 108(4):490497.
[19] So YK, Son YI, Hong SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections[J]. Surgery, 2010, 148 (3):526531.
[20] Giordano D, Gradoni P, Oretti G, et al. Treatment and prognostic factors of papillary thyroid microcarcinoma[J]. Clin Otolaryngol, 2010, 35(2):118124.
[21] Zhou YL, Gao EL, Zhang W, et al. Factors predictive of papillary thyroid microcarcinoma with bilateral involvement and central lymph node metastasis: a retrospective study[J]. World J Surg Oncol, 2012, 10:67.
[22] Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients[J]. J Clin Endocrinol Metab, 2012, 97(4):12501257.
[23] Creach KM, Siegel BA, Nussenbaum B, et al. Radioactive Iodine therapy decreases recurrence in thyroid papillary microcarcinoma,international scholarly research network[J]. ISRN Endocrinol, 2012, 2012:816386.
[24] 杨雪, 梁智勇, 孟超, 等. BRAF突变型甲状腺微小乳头状癌的侵袭性[J]. 中国医学科学院学报, 2013, 35(4):398403. |